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Multidrug-resistant organisms (MDRO) and in par-
ticular multidrug-resistant Gram-negative organisms 
(MRGN) are an increasing problem in hospital care. 
However, data on the current prevalence of MDRO in 
long-term care facilities (LTCFs) are rare. To assess car-
riage rates of MDRO in LTCF residents in the German 
Rhine-Main region, we performed a point prevalence 
survey in 2013. Swabs from nose, throat and perineum 
were analysed for meticillin-resistant Staphylococcus 
aureus (MRSA), perianal swabs were analysed for 
extended-spectrum beta-lactamase (ESBL)-producing 
organisms, MRGN and vancomycin-resistant entero-
cocci (VRE). In 26 LTCFs, 690 residents were enrolled 
for analysis of MRSA colonisation and 455 for analysis 
of rectal carriage of ESBL/MRGN and VRE. Prevalences 
for MRSA, ESBL/MRGN and VRE were 6.5%, 17.8%, and 
0.4%, respectively. MRSA carriage was significantly 
associated with MRSA history, the presence of uri-
nary catheters, percutaneous endoscopic gastrostomy 
tubes and previous antibiotic therapy, whereas ESBL/
MRGN carriage was exclusively associated with uri-
nary catheters. In conclusion, this study revealed no 
increase in MRSA prevalence in LTCFs since 2007. In 
contrast, the rate of ESBL/MRGN carriage in German 
LTCFs was remarkably high. In nearly all positive resi-
dents, MDRO carriage had not been known before, 
indicating a lack of screening efforts and/or a lack of 
information on hospital discharge. 
Introduction
Multidrug-resistant organisms (MDRO) are an increas-
ing problem in hospital care worldwide. In Germany, 
according to data from the Antibiotic Resistance 
Surveillance System (ARS) and the European 
Antimicrobial Resistance Surveillance Network (EARS-
Net) system, the meticillin-resistant Staphylococcus 
aureus (MRSA) rates have not increased since 2008, 
with a slight decrease from 22% in 2010 to 16% in 2012 
in the hospital setting [1-3]. However, an increase in 
the prevalence of multidrug-resistant Gram-negative 
organisms (MRGN) has been observed in the past dec-
ade [3,4], including a sharp increase in carbapenem-
resistant organisms (CRO) [3,5,6]. MDRO are regarded 
as a potentially serious threat to elderly people living 
in long-term care facilities (LTCFs). Although various 
studies on the prevalence of MRSA in LTCFs in Germany 
[7-13] and other European countries [14-25] have been 
published (< 1% in the Netherlands and Sweden, > 20% 
in Ireland and the United Kingdom (UK)), studies on the 
prevalence of MRGN such as extended-spectrum beta-
lactamase (ESBL)-producing Enterobacteriaceae and 
vancomycin-resistant enterococci (VRE) among nursing 
home residents in German and in European LTCFs are 
scarce [7,14,24,26,27]. Although an increasing trend in 
the occurrence of ESBL-producing Enterobacteriaceae 
and even CRO is found in hospitals all over Europe 
[1,3,28,29], a lack of knowledge on multidrug-resistant 
organisms (MDRO) in nursing homes has to be stated. 
Notably, residents of LTCFs may present various risk 
factors for MDRO carriage and/or transmission (e.g. 
older age, comorbidities, medical devices or recurrent 
antibiotic treatments) [30,31]. To issue recommenda-
tions for MDRO screening of LTCFs residents, e.g. upon 
admission to hospital, a better knowledge of current 
colonisation rates and the most relevant clinical risk 
factors is needed. The aim of our study was to assess 
the current prevalence of MDRO, specifically MRSA, 
ESBL/MRGN and VRE, obtained by case history and by 




The study was approved by the Ethics committee of 
the Chamber of Physicians, County of Hesse, Germany. 
Inhabitants of 26 LTCFs in the Rhine-Main region were 
asked to take part in this study and to agree to hav-
ing swabs from nose, throat and perineum taken for 
analysis for MDRO. Data on sex, age, health character-
istics such as hospital stay, antibiotic therapy during 
the previous three months and surgery within the past 
30 days, current healthcare-associated infection and/
or antibiotic therapy, presence of urinary or vascular 
catheters, pressure sores and other wounds as well 
as case history for MDRO were obtained for all partici-
pants, using the well-established HALT questionnaire 
(healthcare-associated infections in LTCFs) in Europe 
[32]. An identical data set was obtained from non-par-
ticipants in order to assess potential bias in participa-
tion. Information on healthcare-associated infections 
was obtained according to the McGeer criteria 1990 
[33] and adapted by the HALT project, i.e. physician 
diagnosis of infection had been included as a criterion 
in all categories of infection in order to avoid under-
estimation of the infection rate due to lack of on-site 
diagnostic testing [32].
Anterior bilateral nasal, throat and perianal swabs were 
collected from April to May 2013 using culture swabs 
with Amies collection and transport medium (Hain 
Lifescience, Germany). Swabs from nose, throat and 
perineum were taken from residents, with their written 
consent. The swabs from nose and throat were tested 
for MRSA, while perianal swabs were tested for the 
presence of VRE and ESBL/MRGN. All specimens were 
collected by the local nursing personnel. Collected 
swabs were processed within 24 hours by streaking 
on Brilliance MRSA 2 agar (Oxoid, Germany), ChromID 
VRE agar (bioMérieux, Germany) and CHROMagar 
ESBL (Mast Diagnostics, Germany) for the detection 
of MRSA, VRE and MRGN including ESBL-producing 
Enterobacteriaceae, respectively. Definite identifica-
tion of presumptive S. aureus, enterobacterial species 
and enterococci was confirmed by the VITEK MS matrix-
assisted laser desorption ionisation time-of-flight 
mass spectrometry (MALDI-TOF MS) automated sys-
tem (bioMérieux, Germany). The determination of the 
antimicrobial susceptibility profiles and classification 
as ESBL/MRGN, MRSA and VRE was performed by the 
VITEK 2 identification system (bioMérieux, Germany), 
using either VITEK N263 (Enterobacteriaceae), P586 
(Enterococcus spp.) or P580 (Staphylococcus spp.) anti-
microbial susceptibility testing (AST) cards according 
to standard laboratory procedures under strict quality-
controlled criteria (laboratory accreditation according 
to DAkkS and DIN15189:2007 standards; certificate 
number D-ML-13102-01-00, valid through 06.12.2015). 
MRSA phenotype was confirmed by detection of the 
mecA gene as described [34]. In addition, PCR for the 
luk-PV (encoding Panton-Valentine leukocidin) gene 
was performed as described [35]. MRSA spa-typing was 
used as first-line typing tool as described previously 
[36]. We used the BURP algorithm for attribution to 
clonal complexes (www.ridom.de/staphtype/support). 
For isolates with spa-types which are not very often 
detected we used multilocus sequence typing (MLST) 
according to Enright et al. [37] as well as the S. aureus 
MLST database (www.mlst.net) for allelic profile analy-
sis. Finally, prevalence rates, Kruskal–Wallis tests and 
univariate analysis (odds ratios) were performed with 
SPSS 15 software, IBM, Stanford University, United 
States (US). 
Results
The total population, i.e. residents present in the 26 
homes on the day of the survey, numbered 2,404. 
Of these residents, 690 (26%) took part in the MRSA 
analysis, while only 455 of them (19%) consented 
also in anal swabs for analysis of ESBL and MRGN. 
Characteristics of the total LTCF population and the 
final study participants are summarised in Table 1. 
There were no significant differences between partici-
pants and non-participants regarding sex, urinary and 
vascular catheters, pressure sores, impaired mobility, 
incontinence and disorientation, hospital stay in the 
past three months, surgery in the past 30 days, current 
infection or antibiotic therapy. The participants exhib-
ited more ‘other wounds’, they were older, had more 
often a percutaneous endoscopic gastrostomy tube 
than the non-participants, and they had more often 
been treated with antimicrobials in the previous three 
months. Prevalence rates of positive MDRO anamnesis 
were lower in the group of the participants than in the 
total group (not significant). Prevalence for MDRO in 
swab cultures exceeded the prevalence of case history 
for MDRO by far: MRSA 6.5% vs 0.7%, ESBL 17.8% vs 
0.7%, VRE 0.4% vs 0%. 
From 45 detected MRSA-isolates, only 36, which all 
were positive for mecA gene but negative for luk-PV 
gene, could be recultured from stored samples and 
subjected to spa-typing. Of these 36, 21 were attrib-
uted to clonal lineage ST225, 10 to clonal complex 22, 
four to clonal complex 5 (other than ST225) and one to 
clonal complex 45. Antibiotic resistance phenotypes of 
the isolates were typical of those usually observed for 
MRSA attributed to ST225 and CC22 (resistance to beta-
lactams, erythromycin, clindamycin, fluoroquinolones) 
[38]. Only one isolate exhibited mupirocin resistance, 
and three isolates of ST225 were in addition resistant 
to fusidic acid.
According to the criteria of the German Commission on 
Hospital Hygiene and Infection Prevention (KRINKO) 
[39], Gram-negative pathogens are classified as 
3MRGN when resistant to three antibiotic groups 
(ureidopenicillins, third- and/or fourth-generation 
cephalosporins and fluoroquinolones) represented by 
piperacillin, cefotaxime and/or ceftazidime and cip-
rofloxacin as guiding agents to define resistance for 
each group. ESBL/MRGN were isolated from swabs 
from 81 residents; 25 of them tested positive for ESBL 
and 56 were 3MRGN. Among the 25 residents carrying 
ESBL-producing Enterobacteriaceae, we identified 22 
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Escherichia coli, two Klebsiella pneumonia, and one 
Klebsiella oxytoca isolate. Resistance against three 
antibiotic groups (3MRGN) was detected in 43 E. coli, 
eight K. pneumoniae, two Acinetobacter baumannii, one 
Enterobacter spp. and two Pseudomonas aeruginosa 
isolates. 4MRGN (Gram-negative Enterobacteriaceae 
resistant against four antibiotic groups, namely those 
mentioned above for 3MRGN plus resistance to imi-
penem and/or meropenem) according to the German 
KRINKO guideline [39] were not detected. Perianal car-
riage for VRE was observed in two residents (0.4%).
In 43 of 45 of the residents with MRSA colonisation, 
the colonisation status was previously unknown. 
Colonisation in both VRE cases and in 79 of 81 resi-
dents positive for ESBL-producing Enterobacteriaceae 
had not been known before this study either. In three 
of five residents with a documented MRSA history, 
detection of MRSA was not confirmed in our study. 
In Table 2, patient numbers and odds ratios for MRSA 
and ESBL colonisation are shown. Medical history for 
MRSA (OR = 9.9; 95% CI: 1.6–61.1), urinary catheter 
(OR = 4.2; 95% CI: 2.1–8.7), percutaneous endoscopic 
gastrostomy tube (OR = 2.7; 95% CI: 1.2–6.2) and anti-
biotic therapy during the last three months (OR = 2.6; 
95% CI: 1.3–5.1) proved to be significantly associated 
with MRSA colonisation. The odds ratios for ESBL/
MRGN carriage were significantly increased by having 
a urinary catheter (OR = 1.9; 95% CI: 1.0–3.8). All other 
characteristics including anamnesis for MDRO (OR > 4) 
proved not to be significant risk factors for ESBL colo-
nisation. One of the two residents with VRE was bedrid-
den and exhibited pressure sores, but neither of them 
had a catheter or exhibited other risk factors such as a 
hospital stay during the previous three months. 
Table 1
Characteristics of residents in 26 nursing homes, prevalence of infections, antibiotic therapy, MDRO anamnesis and 
colonisation status, Rhine-Main district, Germany, April–May 2013 (n = 2,404)
Population characteristics
All residents Participants KW test p-value 
participants vs  
non-participantsn = 2,404 % n = 690 %
Age > 85 yearsa 1,184 49.3 369 53.5 0.009
Male 679 28.2 200 29.0 0.620
Had urinary catheter 225 9.4 63 9.1 0.800
Had vascular catheter 10 0.4 4 0.6 0.430
Had pressure sores 86 3.6 28 4.1 0.424
Had other wounds 129 5.4 47 6.8 0.047
Were disorienteda 1,243 51.7 352 51.0 0.648
Had impaired mobility 1,197 49.8 362 52.5 0.102
Hospital stay in previous 3 months 333 13.9 101 14.6 0.486
Had surgery in the past 30 days 37 1.5 13 1.9 0.385
Were incontinent 1,683 70.0 484 70.1 0.958
Had percutaneous endoscopic gastrostomy tube 134 5.6 55 8.0 0.001
Had antibiotic therapy during previous 3 months 309 12.9 109 15.8 0.006
Prevalence of all infections 64 2.7 18 2.6 0.914
Prevalence of oral antibiotic therapy 33 1.4 6 0.9 0.178
Prevalence MDRO vs anamnesis
MRSA 32 1.3 5 0.7 0.099
ESBL 18 0.7 5 0.7 0.929
VRE 0 0 0 0 1
Prevalence of MDRO colonisation (analysis)
MRSA NA NA 45 6.5 NA
ESBL NA NA 81b 17.8 NA
VRE NA NA 2b 0.4 NA
ESBL: extended-spectrum beta-lactamase; KW: Kruskal–Wallis; MDRO: multidrug-resistant organisms; MRSA:  meticillin-resistant 
Staphylococcus aureus; NA: not applicable/not available; VRE: vancomycin-resistant enterococci.
a  Information missing for one person. 
b  455 of 690 participants were tested for ESBL and VRE.
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Discussion
Our point prevalence study on MDRO such as MRSA, 
ESBL/MRGN and VRE in residents of LTCFs in the Rhine-
Main district in Germany revealed a high MRSA preva-
lence compared with hospital settings, rehabilitation 
and dialysis units in Germany [40], and a much higher 
prevalence for ESBL/MRGN carriage, whereas VRE had 
a very low prevalence in the studied LTCFs.
Our study has the following limitations: Of the 214 LTCFs 
located in in the Rhine-Main district, the 83 members 
of the MDRO-network Rhine-Main were asked to partic-
ipate and 26 of them finally participated in this study. 
With informed consent being necessary for investiga-
tion of MDRO colonisation in nursing home residents 
in Germany, we were able to enrol only 690 (29%) of 
all residents in the MRSA study and 455 (19%) in the 
ESBL/MRGN study. Our study has features of cluster 
sampling, which could lead to wider confidence inter-
vals. Participants had significantly more often reported 
on antibiotic therapy in the past three months than 
non-participants and were more often supplied with a 
percutaneous endoscopic gastrostomy tube. However, 
no significant differences between participants and 
non-participants were found regarding sex, impaired 
mobility, disorientation, faecal or urinary incontinence, 
urinary and vascular catheter etc. Residents with a 
positive case history for MRSA, ESBL or VRE were not 
represented more than other residents in the MDRO 
analysis. Therefore, the hypothesis that residents with 
positive MDRO anamnesis may take advantage of the 
opportunity to receive an MDRO analysis free of charge 
and thus would be overrepresented in the study did 
not prove to be true. Thus, although the number of 
Table 2
Numbers and odds ratios of nursing home residents with MRSA and with ESBL/MRGN colonisation, Rhine-Main district, 












positive n = 81 ESBL/MRGN  OR
n % n % OR 95% CI n % n % OR 95% CI
Aged > 85 yearsa 343 53.2 25 55.6 1.097 0.597–2.015 201 53.7 44 54.3 1.024 0.632–1.658
Male 183 28.4 17 37.8 1.529 0.817–2.862 111 29.7 18 22.2 0.677 0.383–1.196
Had urinary catheter 51 7.9 12 26.7 4.228 2.058–8.686 36 9.6 14 17.3 1.962 1.003–3.837
Had vascular 
catheter 3 0.5 1 2.2 4.856 0.495–47.652 3 0.8 0 0.0 0.821 0.786–0.857
Had pressure sores 24 3.7 4 8.9 2.520 0.835–7.607 18 4.8 3 3.7 0.761 0.219–2.646
Had other wounds 41 6.4 6 13.3 2.263 0.905–5.654 29 7.8 7 8.6 1.125 0.475–2.667
Were disorienteda 323 50.1 28 62.2 1.637 0.879–3.049 199 53.2 48 59.3 1.279 0.786–2.083
Had impaired 
mobility 332 51.5 30 66.7 1.880 0.992–3.560 197 52.7 52 64.2 1.611 0.980–2.650
Had hospital stay in 
previous 3 months 95 14.7 6 13.3 0.889 0.366–2.158 61 16.3 9 11.1 0.641 0.304–1.351
Had surgery in the 
past 30 days 13 2.0 0 0.0 0.933 0.915–0.952 5 1.3 3 3.7 2.838 0.664–12.125








95 14.7 14 31.1 2.610 1.339–5.088 61 16.3 10 12.3 0.723 0.353–1.480
Prevalence of all 
infections 15 2.3 3 6.7 2.995 0.834–10.755 12 3.2 3 3.7 1.160 0.320–4.209
Prevalence of oral 
antibiotic therapy 6 0.9 0 0.0 0.934 0.916–0.953 4 1.1 0 0.0 0.820 0.786–0.857
Prevalence MDRO vs anamnesis
MRSA 3 0.5 2 4.4 9.938 1.617–61.069 2 0.5 2 2.5 4.709 0.653–33.933
ESBL 5 0.8 0 0.0 0.934 0.916–0.953 1 0.3 1 1.2 4.663 0.289–75.329
VRE 0 0 0 0 NA NA 0 0.0 0 0.0 NA NA
CI: confidence interval; ESBL: extended-spectrum beta-lactamase; MDRO: multidrug-resistant organisms; MRSA: meticillin-resistant 
Staphylococcus aureus; NA: not analysed; OR: odds ratio; VRE: vancomycin-resistant enterococci.
a  Information missing for one person. 
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participating LTCFs and the response rate of 29% (19% 
for the ESBL study) among residents was rather low, 
there is no obvious indication for bias in our study, 
so that the data can be regarded as representative for 
LTCFs in the Rhine-Main region in Germany in 2013.
The point prevalence of MRSA colonisation was 6.5% 
and thus much higher than in earlier studies in 2000–
01 in Germany [8,9,11,13], but since 2007, the MRSA 
prevalence in LTCFs in Germany has not increased fur-
ther and remained between 6.5% and 9.2% [7,10,12]. 
The MRSA prevalence we observed was lower than in 
MRSA surveys in recent years in the US [41-45], China 
[46], the UK [16], France [20], Ireland [15], and Italy [24], 
but higher than in the Netherlands and Sweden [14,22] 
(Table 3).
All MRSA isolates were attributed to clonal lineages 
(ST) and/or clonal complexes (CC) that are prevalent 
in German hospitals, in particular ST225 is widely dis-
seminated in the west of Germany [47]. These results 
indicate primary hospital origin. Prevalence of these 
Table 3
MDRO in residents of long-term care facilities in Frankfurt am Main compared with other studies in Germany and abroad 
2000–13
Country Year of investigation
LTCFs Residents tested MRSA ESBL VRE
Reference
n n % % %
Germany
Berlin 1999 NR NR NR NR 4.2 [26]
Different regions 2000 32 1,342 2.4 NR NR [8]
Frankfurt am Main 2000 8 159a 2.5 NR NR [8]
Heidelberg 2000/01 47 3,236 1.1 NR NR [13]
North Rhine-Westphalia 2000/01 30 1,057 3.1 NR NR [11]
Frankfurt am Main 2001 6 319 0.3 NR NR [9]
Frankfurt am Main 2007 8 178 9.0 11.2 0 [7]
Hessen 2010/11 11 240 NR 9.6 NR [27]
Brunswick 2011 32 1,827 7.6 NR NR [12]
Frankfurt am Main 2012 8 184 9.2 26.7 2.7 [10]
Rhine-Main region 2013 26 690b 6.5 17.8 0.3 This study
Europe
France 2004 1 109 37.6 NR NR [20]
Slovenia 2005 1 107 9.3 NR NR [18]
Belgium 2005 60 2,953 19.9 NR NR [19]
Spain 2005 9 1,377 16.8 NR NR [23]
Italy 2006 2 551 7.8 NR NR [17]
United Kingdom 2007 39 715 22.0 NR NR [16]
Ireland 2007 45 1,111 23.3 NR NR [15]
Italy 2008 1 120 38.7 64 NR [24]
Spain 2009/10 17 744 10.6 NR NR [21]
Luxembourg 2010 19 954 7.2 NR NR [25]
Sweden 2010 9 495 0 3.0 0 [14]
The Netherlands 2011 NR 1,268 0.3 NR NR [22]
Other countries
United States 1998 1 117 24 33 3.5 [45]
Australia 2000 8 292 NR NR 3.1 [55]
United States 2008 1 84 28 51 4 [43]
United States NR 1 160 27.5 NR NR [41]
United States, California 2008/09 NR 1,000 30.7 NR NR [44]
Australia, Melbourne 2010 3 119 NR 12 2 [52]
United States 2006/07 1 161 11.8 22.8 0.6 [42]
China 2011 40 2,020 21.6 NR NR [46]
ESBL: extended-spectrum beta-lactamase; LTCF: long-term care facility; MDRO: multidrug-resistant organisms; MRSA: meticillin-resistant 
Staphylococcus aureus; NR: not reported (in the main text or abstract only); VRE: vancomycin-resistant enterococci.
a  Residents were a subgroup of 1,342 residents tested by Heuck et al. [8] all over Germany, 2000. 
b  455 of them were tested for both ESBL and VRE. 
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clonal lineages was also reported in a study from 2006 
in the west of Germany bordering the Netherlands [48]. 
None of the isolates reported here were attributed to 
community-associated MRSA (CA-MRSA) or livestock-
associated MRSA (LA-MRSA). That CA-MRSA can rep-
resent a substantial proportion of MRSA in nursing 
home residents has been reported from the US [49], 
and LA-MRSA has been identified among isolates from 
Dutch nursing homes [50]. In Germany, CA-MRSA is not 
common so far, nor is LA-MRSA as nasal coloniser and 
infectious agent in regions of Germany with low density 
of livestock farming such as the Rhine-Main region [51]. 
As all our isolates were susceptible to antibiotics that 
are recommended as treatment alternatives for MRSA 
infections, e.g. vancomycin, teicoplanin, linezolid, 
daptomycin, tigecycline, rifampicin and cotrimoxa-
zol, calculated therapy of severe infections should be 
unproblematic.
Regarding ESBL and VRE carriage, only two other stud-
ies in German LTCFs, not done in Frankfurt am Main 
[7,10], have been published since 1999 [26,27]. ESBL/
MRGN prevalence in our studies was 11.2% up to 26.7% 
[7,10] and therefore much higher than MRSA prevalence. 
Three studies from LTCFs in the US and one in Italy 
exhibited higher prevalence rates for ESBL-producing 
bacteria than our study [24,42,43,45], whereas in 
Australian and especially in Swedish LTCFs, ESBL prev-
alence rates were lower than in the Rhine-Main region 
[14,52] (Table 3). However, in all studies, ESBL rates 
exceeded those of MRSA by far [7,10,24,42,43,45]. 
Prevalence rates of MRSA and ESBL/MRGN in the LTCF 
residents in our study were even higher than those in 
a survey on 750 ambulatory patients undergoing hae-
modialysis enrolled in the Rhine-Main area in summer 
2012, presenting 2.1% MRSA, 7.5% ESBL and 5.5% VRE 
prevalence [53].
Compared with studies on MRSA in LTCFs, only few 
studies on ESBL/MRGN have been published so far, 
with a maximum of 495 participants per study. Our 
study encompassing 455 participants was a compara-
tively large study. In Germany, up to now, MDRO preva-
lence rates in residents from nursing homes have only 
been published for the Rhine-Main region [7,10] and 
the federal state of Hesse [27]. This is striking because 
of the well-known and published increase in MRGN in 
the hospital setting in Germany and abroad.
In Germany, guidelines for hygiene and infection pre-
vention in LTCFs have been published in 2005 [51], 
including recommendations for the care of residents 
with MRSA colonisation. According to these guide-
lines, isolation of those persons is recommended for 
hospitals but does not need to be applied in LTCFs. A 
single room (no isolation), however, is recommended 
if the resident with MRSA colonisation or their room-
mate exhibits risk factors such as medical devices or 
wounds. In 2012, KRINKO published a guideline on the 
management of patients carrying 3MRGN and 4MRGN 
[39]. It recommends that patients with 3MRGN are 
isolated in risk areas such as intensive care units only, 
whereas patients with 4MRGN must be cared for in sin-
gle rooms in combination with barrier nursing in all hos-
pital wards. Although the guideline primarily addresses 
the hospital setting, the KRINKO expert panel recom-
mends that in other healthcare settings such as LTCFs, 
hygienic measurements for MRGN should not exceed 
those defined for MRSA [39]. Therefore, a high stand-
ard of hygiene should be applied to residents with 
ESBL/MRGN, but restriction of their mobility in the 
home and their contact to other residents is not neces-
sary. Staff, however, need to be well informed about 
new and emerging antibiotic-resistant organisms and 
must observe good hygiene for the protection of other 
residents and themselves. Although 4MRGN have as 
yet not been detected in the residents in our studies, it 
can be hypothesised that this may soon be the case as 
4MRGN rates are continuously increasing in Germany 
and Europe [54].
In conclusion, the data suggest that MRSA prevalence 
in LTCFs in the Rhine-Main region is stable, but a high 
ESBL/MRGN carriage in LTCFs is recognised. No CRO 
have been detected yet. In nearly all residents with 
MDRO, the MDRO carriage had not been known before, 
indicating a lack of screening and/or a lack of informa-
tion on hospital discharge. 
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